openPR Logo
Press release

Staphylococcus Aureus Testing Market In-Depth Market Research Report 2027

09-19-2018 03:26 PM CET | Health & Medicine

Press release from: Future Market Insights

Staphylococcus Aureus Testing Market In-Depth Market Research

A wide range of human clinical infection caused by Staphylococcus Aureus such as Skin, soft tissue, bacteremia, infective endocarditis and others are the major infection caused by Staphylococcus Aureus. The increased use of Staphylococcus Aureus testing in the diagnosis of staph infection grow rapidly, due to the availability of the various advanced test to screen the pathogen efficiently. There is a number of tests present in the market for Staphylococcus Aureus testing. The extensive use of Staphylococcus Aureus testing boosts the market growth over the forecast period. Innovation in Staphylococcus Aureus testing gives the accuracy, reliability, efficiency for the end user is expected to fuel the market growth. The use of Staphylococcus Aureus testing in food industries also creates tremendous opportunity during the forecast period.

Staphylococcus Aureus Testing Market: Drivers and Restraint

Growing incidence of Staph infections is the major factor driving the growth of global staphylococcus Aureus testing market. The inappropriate sanitary environment is the major cause for the spread of Staph infections. Staphylococcus Aureus screening is the mandatory screening test prior to taking insulin and growing awareness of bacterial infection across the globe is expected to push the market growth. Advanced rapid diagnostic tests availability also boost the growth of Staphylococcus Aureus Testing Market over the forecast period. However, inadequate reimbursement in developing the region and limited access to regular healthcare may be the restraints for the global staphylococcus Aureus testing market.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5284

Staphylococcus Aureus testing Market: Segmentation

The global market for Staphylococcus Aureus testing segmented by product type, modality, material, end user, and region:

Segmented by Test Type

Coagulase Test

Ancillary Tests

Agar-Based Tests

Nucleic Acid Amplification Tests

Segmented by Application

Pharmaceutical

Clinical

Food Testing

Other

Segmented by End User

Hospitals

Diagnostic Clinics

Food Testing laboratories

Others

Segmented by Region

North America

Latin America

Western Europe

Eastern Europe

APEJ(Asia-Pacific Excluding Japan)

Japan

The Middle East and Africa

Staphylococcus Aureus testing Market: Overview

Huge competition in the market is due to the increased number of service providers. High efficiency and less price on the testing service are the factors for survival in the market. According to the SENTRY Antimicrobial Surveillance Program the prevalence of Staphylococcus Aureus related disease in North America (26.0%), Latin America ( 21.6%) and in Europe ( 19.5%).

By Test type, Staphylococcus Aureus testing can be segmented into Coagulase Test, Ancillary Tests, Agar-Based Tests and Nucleic Acid Amplification Tests

By Application, the global Staphylococcus Aureus testing market is segmented into Pharmaceutical, Clinical, food testing and other

By End-user, Staphylococcus Aureus testing can be segmented into Segmented into Hospitals, Diagnostic Clinics, Food Testing laboratories and others

By region, Staphylococcus Aureus testing market is segmented into North America, Western Europe, Eastern Europe, Latin America, Asia-Pacific excluding Japan, Japan and the Middle East and Africa

Staphylococcus Aureus testing Market: Region-wise Outlook

By region, global Staphylococcus Aureus testing market is segmented into seven key regions viz. North America, Latin America, Western Europe, Eastern Europe, APEJ (Asia-Pacific Excluding Japan), Japan and Middle East & Africa. North America followed by Europe will continue to dominate the global Staphylococcus Aureus testing market attributed to high incidence. Furthermore, the newly developed product in the Staphylococcus Aureus testing is also expected to result in higher demand for Staphylococcus Aureus testing market globally over the forecast period. Asia Pacific excluding Japan is expected to be the emerging region in the global Staphylococcus Aureus testing market.

Request to View TOC @ https://www.futuremarketinsights.com/toc/rep-gb-5284

Staphylococcus Aureus testing Market: Key Market Participants

The key players in the Staphylococcus Aureus testing market are Abbott Laboratories Inc., Siemens Healthcare GmbH, Bio Rad Laboratories Inc., Thermo Fisher Scientific Inc., Roche Diagnostics (H. Hoffman-La Roche Ltd.), STD Rapid Test Kits etc. among others.

ABOUT US:
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.
FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Future Market Insights
U.S. Office
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Web: https://www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Staphylococcus Aureus Testing Market In-Depth Market Research Report 2027 here

News-ID: 1249209 • Views:

More Releases from Future Market Insights

Embedded Intelligence Market to Reach USD 3,424.1 Billion by 2036 as Software-Defined Architectures and Edge AI Accelerate Adoption
Embedded Intelligence Market to Reach USD 3,424.1 Billion by 2036 as Software-De …
NEWARK, United States, August 12, 2026 - The global embedded intelligence market is gaining strong momentum as software-defined architectures, edge AI deployment, over-the-air update capabilities, and intelligent embedded platforms reshape automotive, industrial, consumer, and telecommunications systems. According to Future Market Insights (FMI), the market was valued at USD 1,065.1 billion in 2025 and is expected to reach USD 1,184.4 billion in 2026. Over the forecast period from 2026 to 2036,
Cultivated Meat Bioprocess & Scale-Up Technology Market to Reach USD 5.61 Billion by 2036, Driven by Commercial Scale-Up and Regulatory Validation
Cultivated Meat Bioprocess & Scale-Up Technology Market to Reach USD 5.61 Billio …
According to Future Market Insights, the Cultivated Meat Bioprocess & Scale-Up Technology Market is valued at USD 385.5 million in 2026 and is projected to reach USD 5,607.6 million by 2036, expanding at a 30.7% CAGR during the forecast period. According to the published market study, growth is supported by increasing investment in cultivated meat production infrastructure, rising demand for scalable bioreactors and cell-culture systems, growing adoption of serum-free media,
Global Clinic-Based Rehab Therapy Robots Market: Drivers, Challenges & Opportunities
Global Clinic-Based Rehab Therapy Robots Market: Drivers, Challenges & Opportuni …
NEWARK, Del., Aug. 11, 2026 - The global Clinic-Based Rehab Therapy Robots Market is expanding as hospitals, rehabilitation centers, and specialized clinics increasingly adopt robotic technologies designed to deliver structured, repeatable, and measurable therapy sessions. According to Future Market Insights (FMI), the market is projected to grow from USD 863.0 million in 2026 to USD 3,491.0 million by 2036, registering a 15.0% CAGR during the forecast period. Growth is being supported
Multi-Port Laparoscopic Surgical Robots Market Outlook: Growth Trends, Key Players & Innovations
Multi-Port Laparoscopic Surgical Robots Market Outlook: Growth Trends, Key Playe …
NEWARK, Del., Aug. 11, 2026 - The global Soft-Tissue Surgical Robots (Multi-Port Laparoscopic) Market is entering a period of strong expansion as hospitals and surgical centers increasingly adopt robotic platforms to support minimally invasive procedures across urology, general surgery, gynecology, and other soft-tissue specialties. According to Future Market Insights (FMI), the market is projected to grow from USD 14.4 billion in 2026 to USD 58.3 billion by 2036, registering a

All 5 Releases


More Releases for Aureus

Rise In Prevalence Of Methicillin-Resistant Staphylococcus Aureus Infections: Po …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Through 2025? In recent times, the market size of drugs for methicillin-resistant staphylococcus aureus (MRSA) has seen continuous growth. The market, which was worth $2.35 billion in 2024, is projected to expand to $2.47 billion in
Leading Growth Driver in the Methicillin-Resistant Staphylococcus Aureus (MRSA) …
What market dynamics are playing a key role in accelerating the growth of the methicillin-resistant staphylococcus aureus (mrsa) drugs market? The growth of the methicillin-resistant Staphylococcus aureus drugs market is expected to be fuelled by the rise in Hospital Acquired Infections (HAIs). Patients acquire these infections while being treated at a healthcare center, usually 48 hours or more post admissions. The root causes behind HAIs include contaminated medical apparatus, lax hand
Methicillin-Resistant Staphylococcus Aureus Testing Market Size, Share, Developm …
LP INFORMATION offers a latest published report on Methicillin-Resistant Staphylococcus Aureus Testing Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Methicillin-Resistant Staphylococcus Aureus Testing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million
Methicillin-resistant Staphylococcus Aureus Therapeutics Pipeline Analysis 2018
MRSA infection caused by specific "staph" bacteria that is often resistant to most of antibiotic treatments. S. aureus (SA) is listed as a ‘superbug’ by U.S. Centers for Disease Control and Prevention (CDC). MRSA can either be present harmlessly on the skin (colonization) or enter the body (e.g. through broken skin) and cause an infection. The study analyzed that MRSA infection therapeutics pipeline comprises approximately 52 drug candidates in different
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market – Driver
Methicillin-Resistant Staphylococcus Aureus (MRSA) is a type of staphylococcus aureus, which became resistant to methicillin, amoxicillin, penicillin, oxacillin, and other such commonly used antibiotics. Staphylococcus aureus harbors on the skin and nasal passage of about one third of the world population, which comprises around 33%, as per Centers for Disease Control and Prevention (CDC) review 2015. MRSA can be classified into two types, based on mode of infection – Hospital
Vancomycin Resistant Staphylococcus Aureus Infection (VRSA) Market : Evolving Te …
Global Vancomycin Resistant Staphylococcus Aureus Infection (VRSA) Market: Brief Description Staphylococcus aureus is an anaerobic gram positive bacteria, commonly found in the respiratory tract of human and on the skin. This strain of bacteria is always not pathogenic but remains a major cause for respiratory diseases, skin infections and food poisoning. S.aureus strains often promote infections by producing harmful protein toxins. It is anticipated that approximately 20% of the population